کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2675496 1141793 2015 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Effect of chronic kidney disease on A1C in individuals being screened for diabetes
ترجمه فارسی عنوان
اثر بیماری مزمن کلیه بر روی A1C در افرادی که برای دیابت غربالگری می شوند
کلمات کلیدی
HbA1c؛ بیماری مزمن کلیوی؛ تشخیص دیابت نوع 2
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی


• HbA1c is used for the diagnosis of type 2 diabetes but the validity in kidney disease is unknown.
• Stage 4 and 5 kidney disease is rare (<0.1%) in patients being screened for diabetes.
• Stage 3 kidney disease patients are older and have higher HbA1c measurements than stage <3.
• Multivariable regression analysis shows that kidney disease stage 3 does not affect HbA1c.
• Increasing age, South Asian ethnicity and lower haemoglobin were associated with higher HbA1c.

ObjectiveGlycated haemoglobin (A1C) has been recommended for the diagnosis of type 2 diabetes mellitus. Chronic kidney disease (CKD) is reported to increase A1C. The prevalence of CKD and its association with A1C as a diagnostic test for type 2 diabetes screening in a community population was studied.Research design and methodsAge, gender, ethnicity (white/South Asian), haemoglobin, A1C, fasting glucose and fructosamine were compared in participants with estimated glomerular filtration rate (eGFR) 30–59 (CKD 3) and ≥60 ml/min/1.73 m2 using chi-squared or t-tests. Multivariable linear regression analyses were performed with A1C as the dependent variable; remaining variables were forced into a model to identify correlates with A1C. Data were parametric and expressed as means.ResultsOf 949 participants 83.7% had eGFR ≥60, 16.3% had CKD 3 and only 2 had eGFR <30 (CKD ≥4). Compared with eGFR ≥60, patients with CKD 3 were older [p < 0.001], had higher A1C [6.0% vs. 5.8%, p < 0.001], fasting glucose [5.4 vs. 5.2 mmol/L, p = 0.003] and fructosamine [233.7 vs. 225.8 μmol/L, p < 0.001] but lower haemoglobin [p = 0.006]. After adjustment, gender and CKD stage were not associated with A1C. A1C was associated (p < 0.05) positively with age, South Asian ethnicity, fasting glucose and fructosamine and inversely with haemoglobin levels.ConclusionsSevere CKD (stage ≥4) is rare in primary care patients being screened for type 2 diabetes and its impact on A1C could not be evaluated. Although A1C is higher among patients with CKD stage 3 compared to those with eGFR ≥60, this appeared to be due to the confounding effect of other variables rather than the presence of CKD.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Primary Care Diabetes - Volume 9, Issue 2, April 2015, Pages 142–146
نویسندگان
, , , , ,